voriconazole has been researched along with Liver Dysfunction in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.14) | 18.2507 |
| 2000's | 7 (50.00) | 29.6817 |
| 2010's | 5 (35.71) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, XJ; Gong, GZ; Jiang, YF; Liang, W; Song, BL; Tang, D; Tian, Y; Wang, F; Wang, WL; Xiang, DX; Xiao, YW; Yan, M; Zhang, BK; Zhang, M; Zhao, YC; Zou, JJ | 1 |
| Chen, L; Feng, Y; Lu, J; Xing, Y; Zhai, Y; Zhou, Y | 1 |
| Chen, XJ; Linh Banh, H; Song, BL; Tang, D; Wang, F; Xiang, DX; Xiao, YW; Xu, P; Yan, M; Zhang, BK; Zhang, M; Zhou, HY; Zou, JJ | 1 |
| Chen, L; Liu, K; Liu, Y; Wang, W | 1 |
| Alffenaar, JW; Daenen, SM; de Vos, T; Uges, DR | 1 |
| Hangaishi, A; Imai, Y; Kumano, K; Kurokawa, M; Nannya, Y; Takahashi, T; Ueda, K | 1 |
| Corey, M | 1 |
| Falcone, M; Massetti, AP; Russo, A; Venditti, M; Vullo, V | 1 |
| Hamada, Y; Kuroyama, M; Seto, Y; Yago, K | 1 |
| Ullmann, AJ | 1 |
| Blijlevens, NM; Donnelly, JP; Klont, RR; van der Velden, WJ; Verweij, PE | 1 |
| Lambert, JS; Poulton, MB; Scott, CJ; Taylor, CB | 1 |
| Andriole, VT; George, D; Miniter, P | 1 |
| Girija, R; Hwang, YK; Joo, NH; Tan, L; Tan, P; Tee, GY | 1 |
5 review(s) available for voriconazole and Liver Dysfunction
| Article | Year |
|---|---|
Meta-analysis of the safety of voriconazole in definitive, empirical, and prophylactic therapies for invasive fungal infections.
Topics: Antifungal Agents; Databases, Factual; Drug Tolerance; Humans; Invasive Fungal Infections; Kidney Diseases; Liver Diseases; Odds Ratio; Voriconazole | 2017 |
Modern antifungal therapy for neutropenic fever.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Clinical Trials as Topic; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Echinocandins; Fever; Humans; Immunocompromised Host; Kidney Diseases; Lipopeptides; Liposomes; Liver Diseases; Mycoses; Neutropenia; Pyrimidines; Triazoles; Voriconazole | 2006 |
Invasive aspergillosis in patients with liver disease.
Topics: Aged; Antifungal Agents; Aspergillosis; Caspofungin; Echinocandins; Fatal Outcome; Humans; Lipopeptides; Liver Diseases; Lung; Male; Middle Aged; Pyrimidines; Risk Factors; Triazoles; Voriconazole | 2011 |
Investigation and threshold of optimum blood concentration of voriconazole: a descriptive statistical meta-analysis.
Topics: Age Factors; Antifungal Agents; Drug Monitoring; Female; Humans; Liver Diseases; Male; Mycoses; Odds Ratio; Pyrimidines; Triazoles; Voriconazole | 2012 |
Pharmacological aspects of the new triazole voriconazole.
Topics: Antifungal Agents; Contraindications; Drug Interactions; Humans; Kidney Diseases; Liver Diseases; Pyrimidines; Triazoles; Voriconazole | 2002 |
9 other study(ies) available for voriconazole and Liver Dysfunction
| Article | Year |
|---|---|
Population pharmacokinetics, safety and dosing optimization of voriconazole in patients with liver dysfunction: A prospective observational study.
Topics: Antifungal Agents; Humans; Invasive Fungal Infections; Liver Diseases; Prospective Studies; Voriconazole | 2021 |
Identifying factors affecting the pharmacokinetics of voriconazole in patients with liver dysfunction: A population pharmacokinetic approach.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antifungal Agents; Biological Availability; Dose-Response Relationship, Drug; Drug Monitoring; Female; Humans; Invasive Fungal Infections; Liver; Liver Diseases; Male; Metabolic Clearance Rate; Middle Aged; Models, Biological; Retrospective Studies; Voriconazole | 2019 |
Adrenal and hepatic aspergillosis in an immunocompetent patient.
Topics: Adrenal Gland Diseases; Adrenal Glands; Adult; Antifungal Agents; Aspergillosis; Aspergillus; Combined Modality Therapy; Humans; Immunocompetence; Liver; Liver Diseases; Male; Radiography; Voriconazole | 2015 |
High voriconazole trough levels in relation to hepatic function: how to adjust the dosage?
Topics: Antifungal Agents; Humans; Liver Diseases; Pyrimidines; Triazoles; Voriconazole | 2009 |
Monitoring trough concentration of voriconazole is important to ensure successful antifungal therapy and to avoid hepatic damage in patients with hematological disorders.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Dose-Response Relationship, Drug; Drug Monitoring; Hematologic Neoplasms; Humans; Liver Diseases; Male; Middle Aged; Mycoses; Pyrimidines; Triazoles; Voriconazole; Young Adult | 2009 |
Primary hepatic invasive aspergillosis with progression after rituximab therapy for a post transplantation lymphoproliferative disorder.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antifungal Agents; Antineoplastic Agents; Aspergillosis; Chemical and Drug Induced Liver Injury; Fatal Outcome; Female; Galactose; Graft vs Host Disease; Humans; Liver Diseases; Lymphoproliferative Disorders; Mannans; Middle Aged; Pyrimidines; Rituximab; Splenic Diseases; Stem Cell Transplantation; Transplantation, Homologous; Triazoles; Voriconazole | 2006 |
Invasive Aspergillus fumigatus associated with liver and bone involvement in a patient with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Bone Diseases; Humans; Liver Diseases; Male; Pyrimidines; Triazoles; Voriconazole | 2007 |
Efficacy of UK-109496, a new azole antifungal agent, in an experimental model of invasive aspergillosis.
Topics: Animals; Antifungal Agents; Antigens, Fungal; Aspergillosis; Aspergillus fumigatus; Azoles; Female; Kidney Diseases; Liver Diseases; Lung Diseases, Fungal; Pyrimidines; Rabbits; Triazoles; Voriconazole | 1996 |
Clinical activity of the new triazole drug voriconazole (UK 109, 496) against disseminated hepatosplenic aspergillosis in a patient with relapsed leukemia.
Topics: Antifungal Agents; Antineoplastic Agents; Aspergillosis; Child; Humans; Immunosuppression Therapy; Leukemia, Myeloid; Liver Diseases; Male; Pyrimidines; Splenic Diseases; Triazoles; Voriconazole | 2001 |